Koh, S., Ohsumi, S., Takahashi, M., Fukuma, E., Jung, K. H., Ishida, T., & Balmaña Gelpí, J. (2022). Prevalence of mutations in BRCA and homologous recombination repair genes and real-world standard of care of Asian patients with HER2-negative metastatic breast cancer starting first-line systemic cytotoxic chemotherapy: Subgroup analysis of the global BREAKOUT study.
Citación estilo ChicagoKoh, Su-Jin, Shozo Ohsumi, Masato Takahashi, Eisuke Fukuma, Kyung Hae Jung, Takanori Ishida, y Judith Balmaña Gelpí. Prevalence of Mutations in BRCA and Homologous Recombination Repair Genes and Real-world Standard of Care of Asian Patients With HER2-negative Metastatic Breast Cancer Starting First-line Systemic Cytotoxic Chemotherapy: Subgroup Analysis of the Global BREAKOUT Study. 2022.
Cita MLAKoh, Su-Jin, et al. Prevalence of Mutations in BRCA and Homologous Recombination Repair Genes and Real-world Standard of Care of Asian Patients With HER2-negative Metastatic Breast Cancer Starting First-line Systemic Cytotoxic Chemotherapy: Subgroup Analysis of the Global BREAKOUT Study. 2022.